The tissue transglutaminase (tTG) testing is used for the diagnosis of certain autoimmune diseases, which is mostly restricted to celiac disease. In celiac disease, gluten (a protein found in wheat, barley, rye, and oats) is seen as a foreign invader and in response to it the body mounts an immune response to its enacting enzyme known as transglutaminase (which restricts the proteolysis of the glutin). tTG enzyme gets attacked by the (tTG) IgA and (tTG) IgG. For diagnostic purposes (tTG) IgA is exploited more frequently than the tTG (IgG) as tTG (IgG).
Increasing prevalence of celiac disease drives the growth of the market. According to the World Gastroenterology Organization in 2016, 1% of the total population in western countries was diagnosed with the celiac diseases and the prevalence have substantially increased across the globe. According to Celiac Disease Foundation in 2016, hospitalization have increased by 600% from 1998 to 2013.
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/824
Increasing prevalence of autoimmune diseases mainly celiac disease, increasing geriatric global pool, and increasing investments healthcare drives the market growth. Low healthcare expenditure in developing regions, costs considerations, false positive diagnosis in geriatric population marked due to conditions such as diarrhoea, etc. likely to affect the market growth negatively.
Global tTG testing Market
Some of key players profiled in the report are Quest Diagnostics Incorporated., SQI Diagnostics, Trinity Biotech, ZEDIRA GmbH, Demeditec Diagnostics GmbH, ARUP Laboratories, Cell Science Systems, Bio-Rad Laboratories, Inc., Pfizer Inc., Celimmune, LLC., and others.
The Americas account for a significant market share owing to extensive use of medications and high expenditure on the health care. Additionally, the fastest uptake of new technology in the US drives the global tTG testing market. Additionally, concentration of major research companies and research organizations in the developed countries of this region boost the market growth.
Europe is the second largest market in the world due to high income and healthcare penetration.
Asia Pacific region is expected to grow rapidly. China and India are likely to lead this market due to fast growing healthcare sector during the forecast period.
Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East African market. The African region is expected to witness a moderate growth owing to poor economic and political conditions and poor healthcare development.
Taste the market data and market information presented through more than 50 market data tables and figures spread over 80 pages of the project report. Avail the in-depth table of content (TOC) market synopsis on “global tissue transglutaminase testing market” research report – Forecast till 2023.
The global tissue transglutaminase testing market has been segmented on the basis types and end users.
Based on types, the market has been segmented into serological, biopsy testing, and others. The serological testing is sub-segmented into tissue transglutaminase (tTG) antibody- IgA, serum and tissue transglutaminase (tTG) antibody- IgG, serum.
Based on the end users, the market has been segmented as hospitals clinics, homecare, research organizations, and others.
Access full report @ https://www.marketresearchfuture.com/reports/tissue-transglutaminase-test-market-824
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services.
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America